All NaturalVue Multifocal 1 Day Contact Lenses Articles
-
157Latest Myopia NewsVTI Shares Latest Data From PROTECT Study at ARVO 2024
May 6, 2024 SEATTLE, Wash. — Visioneering Technologies Inc. has shared the latest data from its PROTECT (PROgressive Myopia Treatment Evaluation for...
-
461Latest Myopia NewsVTI Shares Ongoing Results of One-Year PROTECT Trial
January 22, 2024 LAS VEGAS — Visioneering Technologies Inc. (VTI) is sharing results from its ongoing PROTECT Trial (PROgressive Myopia Treatment Evaluation...
-
490ClinicalPROTECT Preliminary Trial Data Supports Safety and Efficacy of NaturalVue Multifocal 1 Day for Myopia Progression Control
sponsored content December 1, 2023 The presentation at the 2023 meeting of the American Academy of Optometry, “Seeing Is Believing: NaturalVue Multifocal...
-
489Latest Myopia NewsVTI Shares One-Year Data from PROTECT Trial at AAO 2023
October 12, 2023 NEW ORLEANS, La. — At the 2023 American Academy of Optometry meeting held here, Visioneering Technologies Inc. shared interim...
-
2.0KClinicalA Pediatric Ophthalmologist’s Take on Myopia Management
April 17, 2023 By Carolyn Lederman, MD I’ve found that it’s been helpful when talking to parents about myopia management to tell...
-
1.4KLatest Myopia NewsVTI’s NaturalVue Enhanced Multifocal Now Available in Canada
July 20, 2022 ATLANTA — Visioneering Technologies Inc.’s NaturalVue Enhanced Multifocal contact lenses are now available in Canada. The lenses feature the...
-
989Latest Myopia NewsVTI Reaches 50% Enrollment Milestone for PROTECT Study
July 13, 2022 ATLANTA – Medical device company and producer of NaturalVue Multifocal 1 Day Contact Lenses, Visioneering Technologies, Inc (ASX:VTI) announced...
-
2.0KLatest Myopia NewsVTI’s NaturalVue Sustains Business for ECPs During Pandemic
June 7, 2021 ATLANTA – U.S.-based medical device company and producer of the NaturalVue (etafilcon A) Multifocal 1 Day Contact Lenses, Visioneering Technologies,...